Abstract
Introduction
Microarray hybridization is a high-throughput technique for measuring the expression level of thousands of genes simultaneously that is widely adopted in biological and medical research. In general, there are four main challenges for analyzing microarray data. First, the data of microarray always has high dimensionality p. For example, the number of probe sets in the Affymetrix U133 Plus 2.0 Array is p > 54000. Second, there is a small sample size n. It is not uncommon for medical applications involving human samples to have small sample size, by which we mean n < 100 [1] [2] [3] [4] [5] [6] . Third, there are some outlying samples. The procedure of generating microarray data is complex; outliers can be experimental artifacts or genuine consequences of biological diversity. If a technical experimental problem is detected, the sample should be corrected during the quality control and normalization phases or removed from analysis dataset otherwise it will influence the following analysis. However, an outlier sample caused by biological diversity may be different from the other outliers, possibly harder to detected and questionable if it is an outlier at all. Fourth, there is always the possibility of labeling errors. The quality of the classifier depends critically on the accurate labeling of the training data. But for many medical applications, labeling a sample or grading a biopsy can be subjective. For example, West et al. analyzed 49 breast tumor samples and identified 9 samples as possibly having the wrong labels [1] .
A fully-automatic assessment of the quality of the microarray data in terms of detection of both outliers and mislabeled samples is particularly important now that is more common to integrate several datasets. For example, OncoMine is a web-based analysis system about human cancer that integrates microarray data from 310 different studies [7] . Obviously, the quality of the data can have an impact on the quality of the results. In this scenario it is not feasible to access the expert opinion for assessing data quality issues in each study so a fully-automatic procedure is desirable.
It is important to clarify the distinction between outliers and mislabeled samples. A vast literature exists on outlier detection and robust analysis methods, namely methods insensitive to the presence of outliers [8] [9] [10] [11] . On the other hand, a mislabeled sample is a sample that is erroneously classified in the original dataset. Misclassified samples can influence successive analysis and some approaches have been proposed to solve this problem. However, there are some approaches to detect "mislabeled sample" in microarray dataset, but they used different names. For example, Lu et al. [12] and Kadota et al. [13] called it as "outlier sample", Furey et al. [14] and Malossini et al. [15] called it as "mislabeled" sample. We argue here that the concept of "outlier" does not describe the characteristics of a mislabeled sample.
There are few papers that specifically focus on mislabeled sample detection. Furey et al. [14] used a SVM on the full datasets (tuning a diagonal factor to achieve the best performance on leave-one-out cross-validation test) and on a specified top-ranked features. Samples which have been consistently misclassified in all tests are identified as suspects. Li et al. [16] used a genetic algorithm in order to select subsets of genes that can potentially discriminate between tumor and normal tissue samples and then each sample is classified according to the class membership of its k nearest neighbors. Kadota et al. [13] tackled the problem of detecting outliers using a technique based on Akaike"s Information Criterion. Lu et al. [12] used a SVM as base classifier on a leave-one-out iterative strategy to find outliers. Malossini et al. [15] proposed two algorithms CL-stability (Classify-stability) and LOOEsensitivity based on the generation of the leave-one-out perturbed classification matrix. The output is a list of suspects for further analysis.
Comparing with the results shown in Furey et al. [14] , Li et al. [16] , Kadota et al. [13] , CL-stability [15, 17] is one of the best approaches for detecting mislabeled samples from microarray data. It is not necessary for CL-stability to do dimensionality reduction, feature selection or determine the distance in a high-dimensionality space. CL-stability proved to be empirically better than other methods on synthetic and real datasets. However, we found that there are some problems about CL-stability when the distinction between outliers and misclassified samples is considered. CL-stability is not good at finding mislabeled-outliers and sometimes CL-stability predicts outliers as suspects of being misclassified. On the other hand, CL-stability does not include a procedure to distinguish between suspects that are outliers that should be excluded from the dataset, and suspects that are mislabeled and consequently should be maintained and re-labeled.
In this paper, our goal is to detect mislabeled samples and automatically correct them, avoiding the pitfall of pointing to outliers as suspects of being misclassified. We propose an algorithm based on CLstability. Which is called as Iterative-CL-Stability with Exclusion (Iterative-CLSWE). Iterative-CLSWE detects samples as mislabeled or abnormal and correct these samples respectively by flipping or exclusion. A sample is flipped if detected as a mislabeled and it is excluded if detected as abnormal and checked more carefully because it is not safe just to flip the label. Iterative-CLSWE is an improvement introduced for ensuring termination. We provide an empirical evaluation of the algorithm using real and synthetic datasets. We evaluate precision, recall, and percent of mislabeled-outliers found to show the performance of our new algorithm to find mislabeled samples. We also evaluate the relative number of outliers that our new algorithms detect as abnormal that were detected as suspects by CL-stability. From the empirical evaluation of Iterative-CLSWE, we find that the Iterative-CLSWE not only can correct the results of CL-stability but also can detect mislabeled samples and better than CL-stability.
In the following sections, we first describe CL-stability algorithm, Iterative-CLSWE algorithm. Secondly, we describe the experimental procedure including generation of synthetic dataset, the public datasets and the evaluation parameters. Finally, we show and discuss the experimental results.
Method

CL-stability Algorithm
CL-stability [15] is an algorithm for detecting mislabeled samples. The basic and important part of CL-stability is the construction of the Leave-One-Out Perturbed Classification matrix L (LOOPC matrix). The elements of the matrix whose dimensions are n*n where n is the number of the samples, are computed as follows. First, the j-th sample is left-out from the dataset, then the label of the i-th sample is flip and the perturbed dataset is used to construct a classifier, finally the resulting classifier is used to classify the j-th left-out sample. The result of the classifier is the Lij element of the L matrix. The principle of CL-stability is to assess the stability of a sample with respect to a small perturbation (just one flip) of the other samples of the dataset. A good or stable sample should be consistently classified, with respect to its original label, and not be easily affected by the correctness of 1 flipped sample elsewhere in the dataset. The CL-stability algorithm identifies a list of samples failing this requirement. A sample is predicted as suspect if it is not stable when other samples are perturbed. The algorithm to construct LOOPC matrix and CL-stability can be found in [15] .
Iterative-CLSWE Algorithm
Iterative-CLSWE brings further the idea of stability used by CL-stability. In CL-stability the stability of a sample under perturbation of the data set is very important for determining whether the sample is a suspect or a normal sample. The main strategy of Iterative-CLSWE is based on three assumptions: (i) CL-stability can correctly detect some mislabeled sample and (ii) if correctly detected and flipped, a sample should be stable under successive runs of CL-stability itself. As a whole, it is an iterative strategy and some mislabeled samples which cannot be detected by CL-stability may be detected. When we flip all the labels of suspect samples and run CL-stability again, if a flipped suspect sample is stably classified into the other class then Iterative-CLSWE will output it as mislabeled sample. If a flipped suspect sample is detected again as suspect in the following run of CL-stability, then Iterative-CLSWE will output it as an abnormal sample. Finally, if one iterative step gives the same results of the previous step then the algorithm will finish. (iii) The abnormal sample is excluded from the dataset S in each iterative step in Iterative-CLSWE. The algorithm of Iterative-CLSWE is shown in Figure 1 .
Figure 1. Algorithm of Iterative-CLSWE
Where Si is the dataset and the meaning of i is ith iterative step. Where A is the mislabeled list of Iterative-CLSWE. Where B is the abnormal list of Iterative-CLSWE. Where Di is a temporary suspect list of ith iterative step of Iterative-CLSWE. The CLS(Si) function is used to run CL-stability with dataset Si. The flipset(Si, Di) function is used to flip the label of sample which is included in Di. The formula of a n is same with formular in [15] and bn= n /3.
Experimental Procedure
In this section, we present the experimental procedure we used to illustrate the problems that CLstability has with the outliers and to test the performance of our new algorithm. In the following, we 
endif
we assigned to the data the "ground truth" in terms of samples that we considered to be mislabeled. We also describe how to use real data to generate realistic synthetic datasets and then four other Colon datasets included in OncoMine. Finally, we describe the performance measure used to evaluate CLstability and Iterative-CLSWE.
Real Dataset
We use three well-known real datasets to test our algorithms: (1) A breast cancer dataset was first presented in West et al., which consists of 49 tumor samples classified as positive to estrogen receptor ER+ or negative ER-.The expression levels of 7129 genes are given for each sample [1] . (2) A colon tissue dataset from Alon et al. which consists of 40 tumor samples and 22 normal samples. A selection of 2000 genes with highest minimal intensity across the samples has been made by Alon et al. [4] . (3) A leukemia dataset from Golub et al., which consists of 25 acute myeloid leukemia and 47 acute lymphoblastic leukemia. The expression levels of 7129 genes are given for each sample [2] .
For establishing the outlier samples of the three datasets we followed what done in [15] . In particular, the samples identified by West et al. and Alon et al. are used, whereas for the leukemia dataset no ground truth is available but there is consent in the literature about one sample be outlier.
Realistic Synthetic Dataset
The real datasets presented in the previous section can be used to generate realistic synthetic datasets. The ground truth of Colon dataset and Breast dataset seems more believable because Alon and West have used the biological experiments prove it respectively. So we used these ground truth and real datasets to generate mislabeled samples, outliers and mislabeled-outliers to test our algorithms. The generation of this dataset follows four steps. Firstly, we remove the mislabeled samples from the Breast and Colon datasets and obtain clean datasets. Secondly, we randomly flip the label of NM samples. Thirdly, we take NO samples which will be modified as outliers and randomly exchange within the sample the values of NNF features. Finally, we take NMO samples among the outliers and flip their labels. Information about the kinds of realistic synthetic datasets we used in the experiments is shown in Table 1 . Table 1 . Project selection matrix rules Where NM is the number of mislabeled samples, NO is the number of outliers, NMO is the number of mislabeled-outliers, NNF is the number of noise features in the outliers.
For example, in the kind denoted by B-4-0-2-2000 we start from the Breast dataset, exclude the samples numbered with 11, 14, 16, 31, 33, 40, 43, 45, 46 and randomly flip the label of four samples, we modify two samples to abnormal samples and flip the label of them, the number of changed features is 2000 and the total number of mislabeled sample is 4+2=6. Analogously, in the kind of realistic synthtetic datasets denoted as C-5-3-0-500 we use Colon dataset to generate a realistic synthetic dataset with 5 mislabeled samples, 3 outliers and 500 noise features that are perturbed in the outliers.
Colon Cancer Datasets from OncoMine
In order to assess the impact of our algorithms against other data we considered the data on Colon cancer collected in OncoMine (Rhodes et al. [7] ). Oncomine collects many cancer study datasets and provide integrated analysis functions and there are 10 studies and 31 analysis about Colon cancer. Only five of the datasets can be directly downloaded from the link provided as of November 2007. We refer to these dataset as Alon (Alon et al. [4] ), Graudens (Graudens et al. [18] ), Hong (Hong et al. [19] ), An Algorithm for Recognizing Mislabeled and Abnormal Samples in Cancer Microarray You Zhou, Enrico Blanzieri, Mengmeng Zhang, Yanchun Liang, Xu Zhou Koinuma (Koinuma et al. [20] ) and Laiho (Laiho et al. [21] ). Alon is the same wich we use in section 3.2 with the name Colon. Graudens is a study to distinguish patient who is resistant or sensitive to therapy at the time of drug presentation realized with cDNA microarrays. The number of samples of Graudens dataset is 60 [22] . The dimension of this dataset is 23232. Hong is a study about causative genes for autosomal dominantly inherited familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer [23] . The number of samples of Hong dataset is 22 and the dimension is 54675. Koinuma is a study about colon cancer specimens with or without the methylation of MLH1 promoter. The number of samples of Koinuma is 40 and the dimension is 22645. Laiho is a study about conventional tumor and serrated tumor. The number of samples of Laiho is 37 and the dimension is 22283. Table 2 presents the results of our new algorithms when run on the real datasets Colon, Breast and Leukemia. The algorithms outputs two lists, one of samples one of samples that are predicted to be mislabeled and one of samples that are predicted to be abnormal. It should be better that the abnormal samples should be excluded from further analysis and the mislabeled samples should be flipped. We cannot compute the performance measures because the ground truth about outliers is unknown. Iterative-CLSWE  T2  T37  N2  N28  T30  T33  T36  N8  N34  N36  Breast  Iterative-CLSWE  14  16  19  31  40  43  Leukemia  Iterative-CLSWE  47  66   Table 3 presents a comparison of the new algorithms against CL-stability and other algorithms as done in Malossini et al. 2006 . For Colon dataset, our algorithms are better than the others, our algorithm can find eight out of nine mislabeled samples and wrongly detect the same two false positives detected by CL-stability. For Breast dataset, our algorithms can find five out of nine mislabeled samples and one false positive. For the leukemia dataset all the algorithms agree on identifying the sample 66 as suspect or mislabeled. In general, Iterative-CLSWE algorithm gives very satisfactory results improving the results of CL-stability. This is consistent with the increase in recall that we observed in the run on the synthetic datasets. For all three datasets, the mislabeled sample list appears to be of high quality, rivaling the mislabeled sample list generated by human experts. Comparing the results on Colon dataset of Table 2 and Table 3 , N2 and N28 are false positive samples predicted by CL-stability, whereas they are predicted as abnormal samples by Iterative-CLSWE. This means that these samples maybe be mislabeled samples or outliers, and needs to be considered for exclusion or checked more carefully before flipping. Table 4 shows the average performance measures of CL-stability and Iterative-CLSWE on 40 runs on different instances of the realistic synthetic datasets. We did not run Iterative-CLSWE on these data because Iterative-CLSWE did not present any problem of termination and the algorithm already provided identical results in the previous tests. From Table 4 , it is possible to notice that Iterative-CLSWE has higher precision and recall values, and also the ability of Iterative-CLSWE for detecting mislabeled-outliers is better than CL-stability. With Colon dataset, Iterative-CLSWE has a high correction rate, it means that less outliers are detected as mislabeled. Above all, Iterative-CLSWE is better than CL-stability to detect mislabeled samples and has a high correction rate when CL-stability predicts a considerable number of outliers as suspects. Table 4 . The results of CL-stability and Iterative-CLSWE on realistic synthetic datasets.
Results and Discussion
Results on Real Dataset
Realistic Synthetic Dataset
CL-stability
Iterative-CLSWE Table 5 presents the results of CL-stability and Iterative-CLSWE run with the Colon datasets found in OncoMine. As for the realistic synthetic dataset we did not run Iterative-CLSWE on these data because Iterative-CLSWE did non presented any problem of termination and the algorithms already provided identical results in the previous tests.The Alon data are the same of the Colon data presented earlier. For the other datasets the ground truth is unknown so it not possible to compute the performance measures. However, the methods detect some samples suspects, mislabeled or abnormal. From table 5, there are some samples with wrong labels except Koinuma study. The error percent of Alon study is 14%. The error percent of Graudens study is 10%. The error percent of Hong study is 9%. The error percent of Laiho is 8%. It will influence the effect of classifier within a small size of number of samples. There are hundreds cancer studies use microarray technology can be available. The automatic approach for detecting this error is necessary and significant. Alon  T2,T30,T33,T36,N2,N28,N34,N36  T30,T33,T36,N8,N34,N36  T2,T37,N2,N28  Graudens  GSM89266, GSM89267,  GSM89272, GSM89274,  GSM89276, GSM89277,  GSM89425, GSM89426,  GSM89430. GSM89266, GSM89267, GSM89272, GSM89274, GSM89276, GSM89277, GSM89282, GSM89429, GSM89430.
Results on Colon Cancer Datasets
GSM89425, GSM89426. 
Conclusion
In this paper, we propose an algorithm base on CL-stability for detecting possibly mislabeled samples and correcting potential error of CL-stability. The principle of this algorithm is based on the stability of the whole dataset. We test the algorithm with real datasets and realistic synthetic datasets, all of the results show that our new algorithm is a useful tool for detecting mislabeled sample and better than CL-stability. The results on Colon cancer dataset which is collected from OncoMine shows that this automatic way for detecting mislabeled samples can prove to be significant for large collection of data coming from heterogeneous studies. In the future, we plan to systematically apply Iterative-CLSWE to OncoMine data.
